Company News

This press release is posted as a service by Angioplasty.Org

Toshiba Receives FDA Approval for
Injector Synchronization Option

Improves Efficiency and Patient Care

TUSTIN, CA — October 30, 2006 — Toshiba America Medical Systems, Inc. announced today it received Food and Drug Administration (FDA) clearance for a new CAN Level 1 injector synchronization option for its Aquilion™ 64- and 32-slice computed tomography (CT) systems. The new option facilitates contrast enhanced CT exams by interfacing the CT scanner to a contrast injection system – giving clinicians the option to activate the contrast and the scanner without leaving the patient's side.

According to Doug Ryan, senior director, CT Business Unit, Toshiba, the new injector protocol gives clinicians the flexibility they need to deliver better patient care while improving productivity. "Patient comfort and efficiency are primary concerns for clinicians, particularly when it comes to diagnostic imaging procedures that can be stressful for patients," said Ryan. "This new option lets clinicians stay close to the patient while starting the system, limits the number of times a technologist has to leave the room and reduces the time required for each scan."

The new injector protocol will be available on all Aquilion CT systems equipped with Toshiba's Version 3.0 software and is field upgradeable. Version 3.0 software supports synchronization of the injector and CT system using the Level 1 scan protocol option.

About Toshiba America Medical Systems
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. Toshiba Medical Systems Corp., an independent group company of Toshiba Corp., is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, Cath & EP Labs, X-ray, Ultrasound, Nuclear Medicine, MRI and information systems. Toshiba Corp. is a leader in information and communications systems, electronic components, consumer products, and power systems. Toshiba has approximately 161,000 employees worldwide and annual sales of $54 billion.

Aquilion™ is a trademark of Toshiba Medical Systems Corporation

Source: Toshiba America Medical Systems, Inc.

Angioplasty.Org Home •  PatientCenter

this press release is posted as a reader service by,
an editorially independent informational health site
which has received unrestricted educational grants from
Medtronic plc, TCROSS NEWS, Toshiba America Medical Systems, Volcano Corporation, Terumo Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY
All content, including text, photos and video
©Copyright Venture Digital LLC 1996-2021